Optimal lymph node harvest in rectal cancer (UICC Stages II and III) after Preoperative 5-FU-based radiochemotherapy. acetone compression is a new and highly efficient method

American Journal of Surgical Pathology

Volumn 36, Issue 2, 2012, Pages 202-213

  Gehoff, Anastasia ^a   Basten, Oliver ^b   Sprenger, Thilo ^a   Conradi, Lena Christin ^a   Bismarck, Carsten ^c   Bandorski, Dirk ^d   Merkelbach Bruse, Sabine ^e   Schneider Stock, Regine ^f   Stoehr, Robert ^f   Wirtz, Ralph M ^f   Kitz, Julia ^g   Müller, Annegret ^a   Hartmann, Arndt ^f   Becker, Heinz ^a   Ghadimi, B Michael ^a   Liersch, Torsten ^a   Rüschoff, Josef ^a,g  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Institute of Pathology   (Germany)

^c Hospital zum heiligen Geist   (Germany)

^d UNIVERSITY HOSPITAL MARBURG   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g Institute of Pathology Nordhessen   (Germany)

Author keywords

Acetone compression; Lymph node retrieval; Neoadjuvant radiochemotherapy; Rectal cancer

Indexed keywords

ACETONE; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; SOLVENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECTUM TUMOR; TRANSPLANTATION;

ACETONE; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECTAL NEOPLASMS; SOLVENTS; TISSUE AND ORGAN HARVESTING;

EID: 84857745821     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31823fa35b     Document Type: Article

References (67)

1. Basten O, Bandorski D, Bismarck C, et al. Acetonkompression. Schnelle, standardisierte Methode zur Untersuchung von Lymphknoten im Gastrointestinaltrakt. Pathologe. 2010;3:218-224.
2. Baxter NN. Is lymph node count an ideal quality indicator for cancer care? J Surg Oncol. 2009;99:265-268.
3. Baxter NN, Morris AM, Rothenberger DA, et al. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: A population-based analysis. Int J Radiat Oncol Biol Phys. 2005;61:426-431. (Pubitemid 40164437)
4. Beresford M, Glynne-Jones R, Richman P, et al. The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol (R Coll Radiol). 2005;17:448-455. (Pubitemid 41136141)
5. Bohmann K, Hennig G, Rogel U, et al. RNA extraction from archival formalin-fixed paraffin-embedded tissue: A comparison of manual, semiautomated, and fully automated purification methods. Clin Chem. 2009;55:1719-1727.
6. Burger M, Denzinger S, Hammerschmied C, et al.Mitogen-activated protein kinase signaling is activated in prostate tumours but not mediated by B-RAF mutations. Eur Urol. 2006;50:1102-1109.
7. Chang GJ, Rodriguez-Bigas MA, Skibber J, et al. Lymph node evaluation and survival after curative resection of colon cancer; systematic review. J Natl Cancer Inst. 2004;99:433-441. (Pubitemid 47073566)
8. de la Fuente SG, Manson RJ, Ludwig KA, et al. Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens. J Gastrointest Surg. 2009;13:269-274.
9. Doll D, Gertler R, Maak M, et al. Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg. 2009;33: 340-347.
10. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12:19-23. (Pubitemid 27138353)
11. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. New York: Springer; 2010.
12. Fang YJ, Pan ZZ, Li LR, et al. MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells. J Exp Clin Cancer Res. 2009;28:132-139.
13. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumours predict clinical outcome. Science. 2006;29:1960-1964. (Pubitemid 44498003)
14. Gentner B, Wein A, Croner RS, et al. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal cancers and their synchronous liver metastases. Anticancer Res. 2009;29:67-74.
15. Ha YH, Jeong SY, Lim SB, et al. Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg. 2010;252:336-340.
16. Habr-Gama A, Perez RO, Proscurshim I, et al. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum. 2008;51:277-283.
17. Havenga K, Enker WE, Norstein J, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients. Eur J Surg Oncol. 1999;25:368-374. (Pubitemid 29364222)
18. Hermanek P, Hermanek P, Hohenberger W, et al. The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis. 2003;18: 335-341. (Pubitemid 36790231)
19. Kenelly R, Winter DC. Quality assurance measures in rectal cancer: caveat utilitor. Gut. 2010;59:139-140.
20. Kim YW, Kim NK, Min BS, et al. The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. J Surg Oncol. 2009;100:1-7.
21. Kobayashi H, Ueno H, Hashiguchi Y, et al. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer. Surgery. 2006;139:516-522.
22. Koh DM, Chau I, Tait D, et al. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2008;71:456-461.
23. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2003;21:2912-2919. (Pubitemid 46621841)
24. Leibold T, Shia J, Ruo L, et al. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol. 2008;26:2106-2111.
25. Liersch T, Gaedcke J, Grade M, et al. Molekulare Marker zur Responseprädiktion beim lokal fortgeschrittenen Rektumkarzinom. Kommt die Individualisierung der Therapie? Onkologe. 2010;16: 779-788.
26. Liersch T, Langer C, Ghadimi BM, et al. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. J Clin Oncol. 2006;24:4062-4068. (Pubitemid 46628475)
27. Luna-Perez P, Rodriguez-Ramirez S, Alvarado I, et al. Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Res. 2003;34:281-286. (Pubitemid 37080580)
28. Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol. 2010;11:835-844.
29. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341:457-460. (Pubitemid 23054519)
30. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol. 2001;19:1976-1984. (Pubitemid 32702542)
31. Mekenkamp LJ, van Krieken JH, Marijnen CA, et al. Pathology Review Committee and the Co-operative Clinical Investigators. Pathology Review Committee and the Co-operative Clinical Investigators. LN retrieval in rectal cancer is dependent on many factors-the role of the tumour, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol. 2009;33: 1547-1553.
32. Mlecnik B, Tosolini M, Charoentong P, et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology. 2010;138:1429-1440.
33. Müller A, Beckmann C, Westphal G, et al. Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study. Int J Colorectal Dis. 2006;21:632-641. (Pubitemid 44446062)
34. Nagtegaal ID, van Krieken JHJM. Role of pathologists in quality control of diagnosis and treatment of rectal cancer. Eur J Cancer. 2002;38:964-972. (Pubitemid 34442324)
35. Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology. 2007;51:141-149. (Pubitemid 47083979)
36. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-312.
37. Nagtegaal ID, van de Velde CJH, van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729-1734. (Pubitemid 34273260)
38. Naschberger E, Croner RS, Merkel S, et al. Angiostatic immune reaction in colorectal carcinoma: impact on survival and perspectives for antiangiogenic therapy. Int J Cancer. 2008;123:2120-2129.
39. Ogino S, Chan AT, Fuchs CS, et al. Molecular pathological epidemiology of colorectal neoplasia: An emerging transdisciplinary and interdisciplinary field. Gut. 2011;60:397-411.
40. Perez RO, Pereira DD, Proscurshim I, et al. Lymph node size in rectal cancer following neoadjuvant chemoradiation-can we rely on radiologic nodal staging after chemoradiation? Dis Colon Rectum. 2009;52:1278-1284.
41. Poeschl EM, Pollheimer MJ, Kornprat P, et al. Perineural invasion: correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer. J Clin Oncol. 2010;28:e358-e360.
42. Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut. 2011;60:116-129.
43. Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol. 2003;4:695-702. (Pubitemid 37407437)
44. Quirke P, Durdey P, Dixon M, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999. (Pubitemid 16005611)
45. Robert Koch Institut. Krebs in Deutschland 2005/2006. Haufigkeiten und Trends 7 Ausgabe. Berlin: Robert Koch-Institut (Hrsg) and Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg); 2010.
46. Rödel C, Arnold D, Liersch T. Rectal cancer. In: Blanke CD, Rödel C, Talamonti MS eds. Gastrointestinal Oncology. A Practical Guide. Berlin, Heidelberg: Springer-Verlag; 2011:379-422.
47. Rödel C, Becker H, Fietkau R, et al. For the German Rectal Cancer Study Group. Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: first results of the German CAO/ARO/AIO-04 randomized phase III trial [abstract]. ASCO Annual Meeting, Chicago; 2011.
48. Rödel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumour regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688-8696. (Pubitemid 46211512)
49. Rullier A, Laurent C, Capdepont M, et al. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol. 2008;32:45-50.
50. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
51. Sauer R, Liersch T, Merkel S, et al. For the German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow up of 11 years [abstract]. ASCO Annual Meeting, Chicago; 2011.
52. Schernhammer ES, Giovannucci E, Kawasaki T, et al. Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut. 2010;59:794-799.
53. Schneider-Stock R, Kuester D, Ullrich O, et al. Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells. J Pathol. 2006;209:95-105.
54. Sermier A, Gervaz P, Egger JF, et al. Lymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent. World J Surg Oncol. 2006;4:29-33.
55. Smith A, Driman DK, Spithoff K, et al. For the Expert Panel on Colon and Rectal Cancer Surgery and Pathology. Guideline for optimization of colorectal cancer surgery and pathology. J Surg Oncol. 2010;101:5-12.
56. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. Oxford: Wiley Blackwell; 2009.
57. Sprenger T, Rothe H, Homayounfar K, et al. Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens-results from a prospective evaluation with extensive pathological work-up. J Gastrointest Surg. 2010;14: 96-103.
58. Sprenger T, Rothe H, Langer C, et al. Comment on "lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival". Am J Surg Pathol. 2009;33:1107; author reply 1108.
59. Swanson RS, Compton CC, Stewart AK. The prognosis of T3NO colon cancer is dependent on the number of lymph nodes examined. Am Surg Oncol. 2003;10:65-71.
60. Thorn CC, Woodcock NP, Scott N, et al. What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis. 2004;6:356-361. (Pubitemid 39236535)
61. Tocchi A, Mazzoni G, Lepre L, et al. Total mesorectal excision and low rectal anatomosis for the treatment of rectal cancer and prevention of pelvic recurrence. Arch Surg. 2001;136:216-220. (Pubitemid 32143847)
62. Van den Brink M, Stiggelbout AM, van den Hout WB, et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without pelvic recurrences. J Clin Oncol. 2004;22:3958-3964. (Pubitemid 41079878)
63. Wang H, Safar B, Wexner SD, et al. The clinical significance of fat clearance lymph node harvest for invasive rectal adenocarcinoma following neoadjuvant therapy. Dis Colon Rectum. 2009;52:1767-1773.
64. Wheeler JM, Waren BF, Mortensen NJ, et al. Quantification of histologic regression of rectal cancer after irradiation: A proposal for a modified staging system. Dis Colon Rectum. 2002;45:1051-1056.
65. Wichmann MW, Müller C, Meyer G, et al. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg. 2002;137:206-210. (Pubitemid 34142139)
66. Wijesuriya RE, Deen KL, Hewavisenthi J, et al. Neoadjuvant therapy for rectal cancer down-stages the tumour but reduces LN harvest significantly. Surg Today. 2005;35:442-445. (Pubitemid 40873805)
67. Wittekind C, Compton C, Quirke P, et al. A uniform residual tumour (R) classification: integration of the R classification and the circumferential margin status. Cancer. 2009;115:3483-3488.